Protein powder has become essential for health and fitness, with options suitable for different goals. Whether for weight loss, muscle gain, or overall nutrition, these powders offer a convenient and efficient way to increase protein intake. Our top picks include Ancient Nutrition’s plant-based powder, Ghost Whey Protein Powder in Cinnabon flavor, Paleovalley’s Grass Fed Beef…
Liquid biopsy is showing promise in identifying the patients with non-small cell lung cancer who will benefit the most from radiation. This non-invasive technique involves analyzing circulating tumor DNA in the blood to determine the genetic makeup of the tumor. The study suggests that patients whose liquid biopsy results show a high level of tumor…
Ionis Pharmaceuticals has reported positive results from the Phase 3 trial of its drug candidate, donidalorsen, for the treatment of hereditary angioedema (HAE). The drug met its main trial goal of reducing the rate of HAE attacks, was well tolerated by patients, and no serious adverse events were reported in the treatment group. Phase 3…
The content is about the RCPI Institute of Medicine Stearne Lecture and Bryan Alton Medal. It includes a photo of the event with individuals such as Prof Anthony O’Regan, Prof Tim O’Brien, Prof Geraldine McCarthy, Prof Dennis McGonagle, Prof Ed McKone, and Dr. Diarmuid O’Shea present. The article is one of 15 free-access articles allowed…
Yonsei University Health System has launched Connect-DTx, a platform that integrates hospitals, insurers, and medical device manufacturers to seamlessly connect the entire care process. The platform allows for the collection of real-time health data from patients using digital therapeutics (DTx) and hospital EMRs, which can be used to personalize treatments. It also facilitates communication with…
The J.P. Morgan Healthcare Conference in San Francisco drew over 8,000 attendees in January 2024, with a focus on science, medicine, and money. The conference showcased the potential of artificial intelligence in drug development, but some attendees were skeptical about the impact AI could have. Weight loss pills were another hot topic, as investors inquired…
The FDA has cleared NeuroSigma’s second-generation Monarch eTNS System for treating pediatric ADHD. The device is smaller and includes a high-resolution color LCD screen and optimized user interface. It is indicated for patients aged 7 to 12 years who are not currently taking ADHD medications. NeuroSigma plans to scale its commercial operations to help treat…
The human blood system undergoes a constant turnover, and different blood cells have varying lifespans. Stem cells in the bone marrow replenish these cells. Changes in these stem cells can lead to blood diseases. Researchers have developed a technique called ReDeeM to trace and monitor the blood cell family tree, shedding light on the changes…
The recent escalation of conflict in Yemen is predicted to worsen the already dire humanitarian crisis in the country and may result in aid groups ending their operations there. The US and UK airstrikes in response to Houthi attacks on commercial ships have led to several international aid groups ceasing their work in western Yemen….
A clinical trial led by Professor Uwe Platzbecker from the University of Leipzig Medical Center tested a new treatment combination for higher-risk myelodysplastic neoplasms (MDS). Symptoms of MDS include rapid progression, severe symptoms, and a transition to acute leukemia. Only intensive treatments like stem cell transplantation and chemotherapy are available to patients with higher-risk MDS….
